Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV903
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,256
Award facts
- Contract value 100% obligated
- $11,256.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,256.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. This is a non-set-aside, competitively awarded contract with a completion date of January 30, 2026, with performance to be fulfilled at the vendor's facility in Conshohocken, Pennsylvania. RINVOQ is a Janus kinase inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, and this order represents a routine pharmaceutical supply delivery supporting military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of an extensive range of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's consistent success in competitively winning delivery orders under this vehicle demonstrates the company's capability to meet federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FV903?
SPE2DR26FV903 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FV903 worth?
The government has obligated $11,256 on SPE2DR26FV903.
Is contract SPE2DR26FV903 an order under another contract?
Yes. SPE2DR26FV903 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV903 competed?
The extent of competition for SPE2DR26FV903 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award